Direct-to-Consumer Drug Advertising Under Fire

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Everyone knows prescription drugs are expensive. The question Sen. Byron Dorgan, D-N.D., wants answered is whether the advertising is driving up the cost.

A Senate consumer-affairs subcommittee will hold a hearing tomorrow to determine whether direct-to-consumer ad vertising of prescription drugs encourages more people to see their doctors, increases the number of prescriptions and ultimately drives up the cost of drugs.

A Dorgan representative said the senator only seeks information. But what advertising lobby groups fear is whether this is just the first step on the road to a bill that will permanently ban such ads.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in